Valeo Pharma Inc
TSX:VPH
Income Statement
Earnings Waterfall
Valeo Pharma Inc
Revenue
|
54.3m
CAD
|
Cost of Revenue
|
-42.7m
CAD
|
Gross Profit
|
11.6m
CAD
|
Operating Expenses
|
-29.8m
CAD
|
Operating Income
|
-18.2m
CAD
|
Other Expenses
|
-10.2m
CAD
|
Net Income
|
-28.4m
CAD
|
Income Statement
Valeo Pharma Inc
Oct-2021 | Jan-2022 | Apr-2022 | Jul-2022 | Oct-2022 | Jan-2023 | Apr-2023 | Jul-2023 | Oct-2023 | Jan-2024 | ||
---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | |||||||||||
Revenue |
14
N/A
|
16
+18%
|
18
+13%
|
18
+2%
|
28
+50%
|
37
+32%
|
45
+24%
|
53
+18%
|
54
+1%
|
54
+1%
|
|
Gross Profit | |||||||||||
Cost of Revenue |
(10)
|
(11)
|
(12)
|
(12)
|
(21)
|
(28)
|
(34)
|
(40)
|
(41)
|
(43)
|
|
Gross Profit |
4
N/A
|
5
+26%
|
6
+19%
|
6
+1%
|
6
+5%
|
9
+37%
|
11
+32%
|
13
+18%
|
13
-3%
|
12
-11%
|
|
Operating Income | |||||||||||
Operating Expenses |
(17)
|
(21)
|
(24)
|
(25)
|
(25)
|
(27)
|
(29)
|
(31)
|
(30)
|
(30)
|
|
Selling, General & Administrative |
(16)
|
(20)
|
(24)
|
(25)
|
(25)
|
(26)
|
(28)
|
(30)
|
(30)
|
(29)
|
|
Depreciation & Amortization |
(0)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
|
Other Operating Expenses |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Operating Income |
(13)
N/A
|
(16)
-29%
|
(18)
-14%
|
(19)
-5%
|
(19)
+1%
|
(19)
+3%
|
(17)
+6%
|
(17)
+1%
|
(17)
+1%
|
(18)
-6%
|
|
Pre-Tax Income | |||||||||||
Interest Income Expense |
(1)
|
(2)
|
(3)
|
(4)
|
(7)
|
(8)
|
(11)
|
(11)
|
(13)
|
(14)
|
|
Non-Reccuring Items |
(0)
|
0
|
0
|
0
|
(0)
|
0
|
0
|
0
|
0
|
0
|
|
Total Other Income |
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(1)
|
(1)
|
3
|
3
|
|
Pre-Tax Income |
(14)
N/A
|
(18)
-30%
|
(22)
-18%
|
(23)
-8%
|
(27)
-15%
|
(27)
-1%
|
(29)
-5%
|
(30)
-4%
|
(28)
+7%
|
(28)
-2%
|
|
Net Income | |||||||||||
Tax Provision |
0
|
0
|
0
|
0
|
1
|
0
|
0
|
0
|
0
|
0
|
|
Income from Continuing Operations |
(14)
|
(18)
|
(22)
|
(23)
|
(26)
|
(26)
|
(28)
|
(29)
|
(28)
|
(28)
|
|
Net Income (Common) |
(14)
N/A
|
(18)
-30%
|
(22)
-18%
|
(23)
-8%
|
(26)
-10%
|
(26)
-1%
|
(28)
-5%
|
(29)
-4%
|
(28)
+3%
|
(28)
-2%
|
|
EPS (Diluted) |
-0.2
N/A
|
-0.24
-20%
|
-0.28
-17%
|
-0.29
-4%
|
-0.32
-10%
|
-0.32
N/A
|
-0.33
-3%
|
-0.35
-6%
|
-0.32
+9%
|
-0.33
-3%
|